Provision of HIV/AIDS-Related Strategic Information and Laboratory Support and Technical Assistance Services in Angola under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH16 160402CONT17

Opportunity Information: Apply for CDC RFA GH16 160402CONT17

The grant opportunity titled "Provision of HIV/AIDS-Related Strategic Information and Laboratory Support and Technical Assistance Services in Angola under the President's Emergency Plan for AIDS Relief (PEPFAR)" is a U.S. government funding announcement administered by the Department of Health and Human Services (HHS), specifically the Centers for Disease Control and Prevention (CDC) through its Center for Global Health (CGH). It is framed as a continuation opportunity, meaning it is intended to extend or continue previously supported work rather than launch an entirely new, open competition. The funding mechanism is a cooperative agreement, which typically indicates a substantial level of involvement from CDC staff in the technical direction, planning, monitoring, and coordination of the project activities, as opposed to a standard grant where the recipient operates more independently.

The program focus is HIV/AIDS and, more specifically, the kind of backbone systems that make a national HIV response measurable and technically reliable: strategic information and laboratory support. In practice, "strategic information" in PEPFAR settings usually refers to activities that strengthen the collection, management, analysis, and use of HIV program data so that decision-makers can track the epidemic, monitor service delivery, evaluate outcomes, and target resources effectively. This can include improvements to routine health information systems, data quality assurance processes, surveillance activities, reporting pipelines, indicator definitions and training, and the development of dashboards and feedback loops so data are used for real-time program improvement. The intent is not just to produce reports, but to build a culture and infrastructure where high-quality data guide planning, resource allocation, and performance management across HIV prevention, testing, treatment, and care services.

The laboratory component signals support for the technical systems that underpin accurate HIV diagnosis and clinical monitoring, and for the broader lab network needed in an effective HIV program. In PEPFAR-supported countries, laboratory support and technical assistance can span strengthening laboratory quality management systems, proficiency testing, standard operating procedures, biosafety, specimen transport systems, equipment maintenance and calibration, supply chain planning for reagents and consumables, and workforce development for lab personnel. It may also include support for laboratory information systems and the linkage of lab data with clinical and public health reporting so that test results are timely, reliable, and usable for patient care and national monitoring. While the summary description provided is brief, the combination of "laboratory support" and "strategic information" strongly indicates an emphasis on the systems that ensure HIV program outcomes can be accurately measured and that clinical services are supported by dependable diagnostics.

Geographically, the work is targeted to Angola and is explicitly tied to PEPFAR, the U.S. government's flagship global HIV/AIDS initiative. That linkage matters because PEPFAR programs operate with specific reporting requirements, performance indicators, and accountability expectations, and they generally emphasize measurable results, partner coordination with national governments, and alignment with national HIV strategies. In a continuation cooperative agreement context, the recipient would typically be expected to maintain and improve established systems, fill technical gaps identified through program reviews, and coordinate closely with CDC, other PEPFAR agencies, and the Angolan Ministry of Health and national reference laboratory structures.

From an administrative standpoint, the opportunity is identified by Funding Opportunity Number "CDC RFA GH16 160402CONT17" and is categorized under Health with CFDA number 93.067, which corresponds to CDC global health assistance activities. The creation date listed is February 13, 2017, with an original closing date of April 18, 2017, placing it within a defined application window. The listing notes "Expected Awards: 10," indicating CDC anticipated making multiple awards or continuing multiple cooperative agreements under this continuation announcement. The award ceiling is shown as "0," which commonly appears in postings when the ceiling is not specified in the public synopsis, is determined by availability of funds, or is otherwise not expressed as a single fixed cap in the summary record.

Eligibility is described as "Others (see text field entitled Additional Information on Eligibility for clarification)," which implies that the detailed eligibility requirements were provided in the full announcement text and may have included restrictions typical of continuation announcements (for example, limiting eligibility to current recipients or to specific types of organizations already operating in the program area). In general, CDC cooperative agreements in global HIV contexts can involve a mix of implementing partners such as non-profits, universities, foundations, and other technical organizations, but the phrase "continuation" strongly suggests that this particular opportunity may have been structured to maintain ongoing work with existing partners rather than bring in entirely new implementers.

Overall, the opportunity is best understood as CDC support, under PEPFAR, for maintaining and strengthening the information and laboratory systems that make HIV programming in Angola effective, accountable, and scientifically grounded. Rather than funding direct clinical service delivery alone, it emphasizes technical assistance and systems strengthening so that HIV services can be tracked accurately, laboratory results can be trusted, and national and PEPFAR stakeholders can make evidence-based decisions about where to focus interventions and how to improve program performance over time.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Provision of HIV/AIDS-Related Strategic Information and Laboratory Support and Technical Assistance Services in Angola under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Feb 13, 2017.
• Applicants must submit their applications by Apr 18, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH16 160402CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: